As confidence in gene-editing therapy grows, investment in regenerative medicines has more than tripled since 2017, according to a new report by the Alliance for Regenerative Medicine.
Regenerative medicine firms raised an impressive $22.7bn last year, breaking the previous record of $19.9bn in 2020 by 14%, according...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?